Investigation of antiviral substances in Covid 19 by Molecular Docking: In Silico Study

Aims: This paper aimed to investigate the antiviral drugs against Sars-Cov-2 main protease (MPro) using in silico methods.
 Material and Method: A search was made for PubChem database such as Bictegravir, Emtricitabine, Entecavir, Lamivudine, Tenofovir, Favipiravir, Hydroxychloroquine, Lopinavir, Oseltamavir, Remdevisir, Ribavirin, Ritonavir were included our study. The protein structure of Mpro (PDB ID: 6LU7) taken from Protein Data Bank (www.rcsb. Org) system Molecular docking performed AutoDock/Vina, a computational program. Protein-ligand interactions with AutoDock Vina 3D visualizations Discovery Studio 2020 N3 inhibitor method used validation.
 Results: In present study, bictegravir, remdevisir lopinavir compounds showed higher binding affinity compared inhibitor, according molecular insertion results. However, favipiravir, emtricitabine lamuvidune detected very low affinity. Other found close inhibitor.
 Conclusion: good results inhibitor. Therefore, they could be inhibitory Sars Cov-2 target.
 Keywords: Sars-CoV-2 Main Protease; Antiviral Drugs; Docking